Subscribe
shutterstock_473806648_amy_kerkemeyer
Amy Kerkemeyer / Shutterstock.com
18 November 2021AmericasAlex Baldwin

Judge approves Pfizer’s $345m EpiPen settlement

EpiPen buyers have secured final approval of a $345 million settlement with Pfizer in a consumer antitrust suit.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
FDA grants Teva approval for first EpiPen generic
17 August 2018   The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.
Europe
EpiPen patent revoked in Europe
2 May 2018   The European Patent Office has revoked a patent covering Mylan’s EpiPen injector after finding that patent amendments contravened the European Patent Convention (EPC).


Editor's picks

AstraZeneca unit faces class-action suit over alleged Soliris monopoly
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

Editor's picks

Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025
Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025
Americas
‘We need the top 50 law firms to stand up’: Will Perkins Coie ignite Trump resistance?
13 March 2025
Americas
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
6 March 2025
Americas
‘Lift as you climb’: Abbott, BMS, Hitachi, LEGO Group counsels explore ‘empowerment’
6 March 2025
Careers
Jones Day adds experienced patent litigators from Weil
4 March 2025

More on this story

Americas
FDA grants Teva approval for first EpiPen generic
17 August 2018   The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.
Europe
EpiPen patent revoked in Europe
2 May 2018   The European Patent Office has revoked a patent covering Mylan’s EpiPen injector after finding that patent amendments contravened the European Patent Convention (EPC).

More on this story

Americas
FDA grants Teva approval for first EpiPen generic
17 August 2018   The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.
Europe
EpiPen patent revoked in Europe
2 May 2018   The European Patent Office has revoked a patent covering Mylan’s EpiPen injector after finding that patent amendments contravened the European Patent Convention (EPC).

More features

Fenwick establishes new Boston office with trio of IP partners from Cooley
How pharma should prep for the six-bill avalanche from Congress
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
USPTO speeds up patent issuance amid widespread agency changes
Lathrop GPM adds portfolio management specialist
Fed Circ decides fate of Orange Book patent covering blockbuster J&J schizophrenia drug
Failure to make findings of fact adds twist to battle over Eliquis in Ireland
Novo Nordisk, Bayer, GSK among giants accused in drug delivery suits